Global Glaucoma Therapeutics Market Research Report 2022

Market Analysis and Insights: Global Glaucoma Therapeutics Market

Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics globally.

The global Glaucoma Therapeutics market size is projected to reach US$ 8201 million by 2028, from US$ 5677.9 million in 2021, at a CAGR of 4.9% during 2022-2028.

The change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period. Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glaucoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glaucoma Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glaucoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glaucoma Therapeutics market.

Global Glaucoma Therapeutics Scope and Market Size

Glaucoma Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Glaucoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Prostaglandin Analogs

Beta Blockers

Alpha Agonists

Carbonic Anhydrase Inhibitors

Ophthalmic Clinic

Hospitals

Ambulatory Surgical Centers

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Allergan

Pfizer

Novartis

Merck

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Glaucoma Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Prostaglandin Analogs

1.2.3 Beta Blockers

1.2.4 Alpha Agonists

1.2.5 Carbonic Anhydrase Inhibitors

1.3 Market by Application

1.3.1 Global Glaucoma Therapeutics Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Ophthalmic Clinic

1.3.3 Hospitals

1.3.4 Ambulatory Surgical Centers

1.4 Study Objectives

1.5 Years Considered

2.1 Global Glaucoma Therapeutics Market Perspective (2017-2028)

2.2 Glaucoma Therapeutics Growth Trends by Region

2.2.1 Glaucoma Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Glaucoma Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 Glaucoma Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 Glaucoma Therapeutics Market Dynamics

2.3.1 Glaucoma Therapeutics Industry Trends

2.3.2 Glaucoma Therapeutics Market Drivers

2.3.3 Glaucoma Therapeutics Market Challenges

2.3.4 Glaucoma Therapeutics Market Restraints

3.1 Global Top Glaucoma Therapeutics Players by Revenue

3.1.1 Global Top Glaucoma Therapeutics Players by Revenue (2017-2022)

3.1.2 Global Glaucoma Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Glaucoma Therapeutics Revenue

3.4 Global Glaucoma Therapeutics Market Concentration Ratio

3.4.1 Global Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Glaucoma Therapeutics Revenue in 2021

3.5 Glaucoma Therapeutics Key Players Head office and Area Served

3.6 Key Players Glaucoma Therapeutics Product Solution and Service

3.7 Date of Enter into Glaucoma Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Glaucoma Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global Glaucoma Therapeutics Forecasted Market Size by Type (2023-2028)

5.1 Global Glaucoma Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Glaucoma Therapeutics Forecasted Market Size by Application (2023-2028)

6.1 North America Glaucoma Therapeutics Market Size (2017-2028)

6.2 North America Glaucoma Therapeutics Market Size by Country (2017-2022)

6.3 North America Glaucoma Therapeutics Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7.1 Europe Glaucoma Therapeutics Market Size (2017-2028)

7.2 Europe Glaucoma Therapeutics Market Size by Country (2017-2022)

7.3 Europe Glaucoma Therapeutics Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8.1 Asia-Pacific Glaucoma Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific Glaucoma Therapeutics Market Size by Country (2017-2022)

8.3 Asia-Pacific Glaucoma Therapeutics Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9.1 Latin America Glaucoma Therapeutics Market Size (2017-2028)

9.2 Latin America Glaucoma Therapeutics Market Size by Country (2017-2022)

9.3 Latin America Glaucoma Therapeutics Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10.1 Middle East & Africa Glaucoma Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa Glaucoma Therapeutics Market Size by Country (2017-2022)

10.3 Middle East & Africa Glaucoma Therapeutics Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11.1 Allergan

11.1.1 Allergan Company Detail

11.1.2 Allergan Business Overview

11.1.3 Allergan Glaucoma Therapeutics Introduction

11.1.4 Allergan Revenue in Glaucoma Therapeutics Business (2017-2022)

11.1.5 Allergan Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Glaucoma Therapeutics Introduction

11.2.4 Pfizer Revenue in Glaucoma Therapeutics Business (2017-2022)

11.2.5 Pfizer Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Glaucoma Therapeutics Introduction

11.3.4 Novartis Revenue in Glaucoma Therapeutics Business (2017-2022)

11.3.5 Novartis Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Glaucoma Therapeutics Introduction

11.4.4 Merck Revenue in Glaucoma Therapeutics Business (2017-2022)

11.4.5 Merck Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Key Players of Prostaglandin Analogs

    Table 3. Key Players of Beta Blockers

    Table 4. Key Players of Alpha Agonists

    Table 5. Key Players of Carbonic Anhydrase Inhibitors

    Table 6. Global Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Glaucoma Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 8. Global Glaucoma Therapeutics Market Size by Region (2017-2022) & (US$ Million)

    Table 9. Global Glaucoma Therapeutics Market Share by Region (2017-2022)

    Table 10. Global Glaucoma Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 11. Global Glaucoma Therapeutics Market Share by Region (2023-2028)

    Table 12. Glaucoma Therapeutics Market Trends

    Table 13. Glaucoma Therapeutics Market Drivers

    Table 14. Glaucoma Therapeutics Market Challenges

    Table 15. Glaucoma Therapeutics Market Restraints

    Table 16. Global Glaucoma Therapeutics Revenue by Players (2017-2022) & (US$ Million)

    Table 17. Global Glaucoma Therapeutics Market Share by Players (2017-2022)

    Table 18. Global Top Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glaucoma Therapeutics as of 2021)

    Table 19. Ranking of Global Top Glaucoma Therapeutics Companies by Revenue (US$ Million) in 2021

    Table 20. Global 5 Largest Players Market Share by Glaucoma Therapeutics Revenue (CR5 and HHI) & (2017-2022)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Glaucoma Therapeutics Product Solution and Service

    Table 23. Date of Enter into Glaucoma Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Glaucoma Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 26. Global Glaucoma Therapeutics Revenue Market Share by Type (2017-2022)

    Table 27. Global Glaucoma Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 28. Global Glaucoma Therapeutics Revenue Market Share by Type (2023-2028)

    Table 29. Global Glaucoma Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 30. Global Glaucoma Therapeutics Revenue Market Share by Application (2017-2022)

    Table 31. Global Glaucoma Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 32. Global Glaucoma Therapeutics Revenue Market Share by Application (2023-2028)

    Table 33. North America Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 34. North America Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 35. Europe Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 36. Europe Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 37. Asia-Pacific Glaucoma Therapeutics Market Size by Region (2017-2022) & (US$ Million)

    Table 38. Asia-Pacific Glaucoma Therapeutics Market Size by Region (2023-2028) & (US$ Million)

    Table 39. Latin America Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 40. Latin America Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 41. Middle East & Africa Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 42. Middle East & Africa Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 43. Allergan Company Detail

    Table 44. Allergan Business Overview

    Table 45. Allergan Glaucoma Therapeutics Product

    Table 46. Allergan Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)

    Table 47. Allergan Recent Development

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Glaucoma Therapeutics Product

    Table 51. Pfizer Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. Novartis Company Detail

    Table 54. Novartis Business Overview

    Table 55. Novartis Glaucoma Therapeutics Product

    Table 56. Novartis Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)

    Table 57. Novartis Recent Development

    Table 58. Merck Company Detail

    Table 59. Merck Business Overview

    Table 60. Merck Glaucoma Therapeutics Product

    Table 61. Merck Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)

    Table 62. Merck Recent Development

    Table 63. Research Programs/Design for This Report

    Table 64. Key Data Information from Secondary Sources

    Table 65. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Glaucoma Therapeutics Market Share by Type: 2021 VS 2028

    Figure 2. Prostaglandin Analogs Features

    Figure 3. Beta Blockers Features

    Figure 4. Alpha Agonists Features

    Figure 5. Carbonic Anhydrase Inhibitors Features

    Figure 6. Global Glaucoma Therapeutics Market Share by Application in 2021 & 2028

    Figure 7. Ophthalmic Clinic Case Studies

    Figure 8. Hospitals Case Studies

    Figure 9. Ambulatory Surgical Centers Case Studies

    Figure 10. Glaucoma Therapeutics Report Years Considered

    Figure 11. Global Glaucoma Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 12. Global Glaucoma Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 13. Global Glaucoma Therapeutics Market Share by Region: 2021 VS 2028

    Figure 14. Global Glaucoma Therapeutics Market Share by Players in 2021

    Figure 15. Global Top Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glaucoma Therapeutics as of 2021)

    Figure 16. The Top 10 and 5 Players Market Share by Glaucoma Therapeutics Revenue in 2021

    Figure 17. North America Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 18. North America Glaucoma Therapeutics Market Share by Country (2017-2028)

    Figure 19. United States Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Canada Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 22. Europe Glaucoma Therapeutics Market Share by Country (2017-2028)

    Figure 23. Germany Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. France Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. U.K. Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. Italy Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. Russia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Nordic Countries Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Asia-Pacific Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Asia-Pacific Glaucoma Therapeutics Market Share by Region (2017-2028)

    Figure 31. China Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Japan Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. South Korea Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. Southeast Asia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. India Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Australia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Latin America Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. Latin America Glaucoma Therapeutics Market Share by Country (2017-2028)

    Figure 39. Mexico Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Brazil Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Middle East & Africa Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 42. Middle East & Africa Glaucoma Therapeutics Market Share by Country (2017-2028)

    Figure 43. Turkey Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 44. Saudi Arabia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 45. Allergan Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)

    Figure 46. Pfizer Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)

    Figure 47. Novartis Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)

    Figure 48. Merck Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)

    Figure 49. Bottom-up and Top-down Approaches for This Report

    Figure 50. Data Triangulation

    Figure 51. Key Executives Interviewed